Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Amyloid Fibrils Grow Asymmetrically

Structural models’ predictions that amyloid fibrils grow symmetrically at both ends is only 20% correct

by Stuart A. Borman
November 8, 2010 | A version of this story appeared in Volume 88, Issue 45

Structural models have predicted that amyloid fibrils, which are associated with and may help cause conditions such as Alzheimer’s disease, grow symmetrically at both ends. Caryn L. Heldt, Shuqi Zhang, and Georges Belfort at Rensselaer Polytechnic Institute have put those models to the test and found them wanting (Proteins: Struct., Funct., Bioinf., DOI: 10.1002/prot.22861). The researchers attached different fluorescent dyes to the protein insulin, which forms amyloid, and to insulin-based fibrils. They then added the two together and used fluorescence to observe how the fibrils grew. “To our surprise, unidirectional growth for insulin fibrils was dominant,” Belfort says. About half of the fibrils behaved this way, about one-fifth grew bidirectionally, and more than a quarter didn’t grow. The findings could have implications for drug screening or drug design, as amyloid therapeutics often aim to inhibit fibril formation or break up existing fibrils. “There are no widely accepted molecular explanations for more than 20 amyloid diseases, and our work adds one small piece to the puzzle,” Belfort says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.